300143.SZ
盈康生命
SZSE · Q 卫生 · CN
CNY 7.41
−3.64%Year over year
Reported trailing growth
- Revenue
- +27.1%
- EBITDA
- —
- EBIT
- +24.8%
- EPS
- -51.7%
- Free cash flow
- +7289.7%
- Operating cash flow
- +59.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +17.7%
- EBITDA
- +9.1%
- EBIT
- +7.3%
- Net income
- -17.4%
- EPS
- -25.0%
- Free cash flow
- +47.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026